Presage Biosciences Announces Strategic Research Alliance with Celgene Corporation

摘要

2013 MAR 20 (VerticalNews) -- By a News Reporter-Staff News Editor at Journal of Engineering -- Presage Biosciences, a leader in discovering effective cancer drug combinations, announced that it has entered into a strategic collaboration agreement with Celgene Corporation under which Presage and Celgene will take advantage of Presage's proprietary technology platform to identify novel drug combinations for solid tumor indications.